Illumina Strikes Deals With Philips, IBM to Interpret Cancer Genomic Data | GenomeWeb

NEW YORK (GenomeWeb) – Illumina announced two separate collaborations today, with Royal Philips and with IBM, to advance the analysis and interpretation of genomic data for cancer.

The company's strategic collaboration with Philips aims to integrate Illumina's sequencing systems and Philips' IntelliSpace Genomics clinical informatics platform and to coordinate marketing and sales of the combined solution.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.

Some science companies will be taking part in next month's March for Science, Fortune reports.

In Genome Research this week: longitudinal study of Burkholderia cenocepacia isolates from cystic fibrosis patients, long-read assembly approach, and more.

Shale oil companies are turning to DNA sequencing to find spots to drill, Reuters reports.